UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Drugs & aging, 2012-04, Vol.29 (4), p.259-273

2012

Link zum Volltext

Verfügbarkeit prüfen

Bladder Pain Syndrome - an Evolution

2nd ed. 2018 edition., 2017

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Current urology reports, 2012-10, Vol.13 (5), p.327-334

2012

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, Vol.32 (10), p.707-714

2012

Link zum Volltext

Verfügbarkeit prüfen

Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome

International Urogynecology Journal, 2009-12, Vol.20 (12), p.1431-1438

2009

Link zum Volltext

Verfügbarkeit prüfen

Considerations for the management of urgency symptoms in patients with overactive bladder syndrome

World journal of urology, 2009-12, Vol.27 (6), p.755-763

2009

Link zum Volltext

Verfügbarkeit prüfen

The Placebo Response: Not Very Pleasing

Current bladder dysfunction reports, 2010-03, Vol.5 (1), p.1-3

Staskin, David R.

2010

Link zum Volltext

Verfügbarkeit prüfen

Urgency and warning time: Is there an urge or compelling need for a new metric?

Current bladder dysfunction reports, 2009-03, Vol.4 (1), p.1-2

Staskin, David R.

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic perspective on the physiology of the lower urinary tract

Urology (Ridgewood, N.J.), 2002-11, Vol.60 (5), p.13-20

2002

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of overactive bladder drugs: Getting ahead of the curve

Current bladder dysfunction reports, 2009-03, Vol.4 (1), p.34-43

2009

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous tibial nerve stimulation (PTNS): A literature-based assessment

Current bladder dysfunction reports, 2009-03, Vol.4 (1), p.29-33

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Overactive Bladder Drugs: Shifting the Curve

Current bladder dysfunction reports, 2011-03, Vol.6 (1), p.51-63

2011

Link zum Volltext

Verfügbarkeit prüfen

Medication and food issues for overactive bladder/lower urinary tract symptoms: When do we eat?

Current bladder dysfunction reports, 2009-06, Vol.4 (2), p.93-97

2009

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy for benign prostatic hyperplasia: Does size matter?

Current bladder dysfunction reports, 2008, Vol.3 (2), p.102-108

2008

Link zum Volltext

Verfügbarkeit prüfen

Neuromodulation: The Percutaneous Approach: Past, Present, Future

Medical Economics, 2014-06, Vol.91 (11), p.1

Staskin, David R

2014

Link zum Volltext

Verfügbarkeit prüfen

Mast Cells and Interstitial Cystitis

Bladder Pain Syndrome - an Evolution, 2017, p.49-50

2017

Link zum Volltext

Verfügbarkeit prüfen

The percutaneous approach: past, present, future

Medical Economics, 2014-06, Vol.91 (11), p.S1

Staskin, David R

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet

Drugs & aging, 2020-09, Vol.37 (9), p.665-676

2020

Link zum Volltext

Verfügbarkeit prüfen

A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

International Urogynecology Journal, 2018-02, Vol.29 (2), p.273-283

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

ThemaMedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(17)

Publikationsform

Sprache

Englisch
(19)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Medicine & Public Health
(16)
Urology
(15)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Urology & Nephrology
(11)
Geriatrics/gerontology
(9)
Gynecology
(9)
Humans
(7)
Bladder
(6)
Urinary Bladder, Overactive - Drug Therapy
(5)
Drug Therapy
(4)
Female
(4)
Internal Medicine
(4)
Pharmacotherapy
(4)
Double-Blind Method
(3)
Male
(3)
Middle Aged
(3)
Nervous System
(3)
Patients
(3)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Bladder Pain Syndrome - an Evolution

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome

Considerations for the management of urgency symptoms in patients with overactive bladder syndrome

The Placebo Response: Not Very Pleasing

Urgency and warning time: Is there an urge or compelling need for a new metric?

Pharmacologic perspective on the physiology of the lower urinary tract

Pharmacokinetics of overactive bladder drugs: Getting ahead of the curve

Percutaneous tibial nerve stimulation (PTNS): A literature-based assessment

Pharmacodynamics of Overactive Bladder Drugs: Shifting the Curve

Medication and food issues for overactive bladder/lower urinary tract symptoms: When do we eat?

Combination therapy for benign prostatic hyperplasia: Does size matter?

Neuromodulation: The Percutaneous Approach: Past, Present, Future

Mast Cells and Interstitial Cystitis

The percutaneous approach: past, present, future

Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet

A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

Aktive Filter

Suchergebnisse filtern